New Frontiers: At the Forefront of Hemophilia Treatment With CHOP

With a stroll down the hallway at Children’s Hospital of Philadelphia, you run into a tremendous knowledge base and expertise to help answer challenging scientific questions in pediatrics. Lindsey George, MD, PhD, director of the Novel Therapeutics for Bleeding Disorders Frontier Program, shares how this combined clinical experience in gene therapy for hemophilia and in other related bleeding disorders leads toward innovative approaches.